Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 1 Study of AUTX-703 in Participants with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes Pending

2025-521394-13-00 Relapsed/refractory Acute Myeloid Leukemia or relapsed/ 1
A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacitu… Pending

2024-517561-16-00 non-small cell lung cancer 4
Tucatinib and trastuzumab in HER3-mutant and HER2-not amplified metastatic breast cancer Pending

2024-519624-24-00 HER3-mutant and HER2-not amplified metastatic breast ca 4
PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOT… Pending

2024-520160-34-00 Adrenocortical carcinoma 4
First time in human (FTIH) study to investigate the safety and preliminary activity of GSK5533524 alone or in combination in adult participa… Pending

2025-524165-25-00 Neoplasms 1
A Phase II, Open-Label, Single-Arm, Multicentre Study of Carboplatin, Paclitaxel, and Tislelizumab in Biomarker-Selected Patients with Resec… Pending

2024-517565-16-00 Resectable Locally Advanced Oral Cavity Squamous Cell C 4
Chemoimmunotherapy in conjunction with blood-brain-barrier opening in patients with newly diagnosed or relapsed primary central nervous syst… Pending

2024-519046-79-00 Primaari aivolymfomaa, ensilinjan hoito tai hoito relap 4
AdaptNK –Cell Therapy for High-risk Myeloid Disease Pending

2025-521962-83-00 Relapsed and/or refractory AML or MDS 9
Neoadjuvant AXITINIB plus AVELUMAB for patients with localized RCC and a moderate to high risk of recurrence Pending

2024-515825-27-00 renal cell carcinoma 4
Anti-PD 1 Brain Collaboration + Radiotherapy Extension: The ABC-X Study Pending

2024-518545-13-00 melanoma brain metastases 4
ORGAN SPARING FOR LOCALLY ADVANCED RECTAL CANCER AFTER NEOADJUVANT TREATMENT FOLLOWED BY ELECTROCHEMOTHERAPY - LARC_ DEEP_CANCERS Pending

2024-519050-37-00 colorectal cancer 4
Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplas… Pending

2024-515362-13-00 Philadelphia-negative myeloproliferative neoplasms are 10
FIRST IN HUMAN PHASE 1 DOSE ESCALATION AND EXPANSION CLINICAL TRIAL TO EVALUATE THE SAFETY, PHARMACOKINETICS AND ANTITUMOR ACTIVITY OF INTR… Pending

2024-517569-18-00 Patients with advanced refractory solid tumors. 1
BARBICAN: A randomised, open-label Phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab… Pending

2024-516236-10-00 Triple-negative breast cancer 4
Repurposed Drugs in Research and Cancer Clinical Trials. The ReDiReCCT trial Vemurafenib Pending

2025-523340-12-00 Glioma 3
Route of nutrition and muscle wasting after oesophagectomy Pending

2023-507649-27-00 Oesophagectomy 6
The CORINTH Trial: Study of Checkpoint Inhibitor Pembrolizumab plus standard chemoradiation in anal cancer Pending

2024-515369-33-00 Anal cancer 8
A study of safety, feasibility and immunologic response of transfering tumor infiltrating lymphocytes with or without dendritic cell vaccina… Pending

2024-519060-40-00 Advanced metastatic malignant melanoma stage 3 or 4 wit 3
A Study Testing the Investigational Drug XmAb541 in people with Advanced Cancer Pending

2025-521981-90-00 Advanced Solid Tumors 1
A First-in-Human Trial of DS3790a in Participants with Hematological Malignancies. Pending

2025-522595-87-00 Hematological Malignancies 7
Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemo… Pending

2023-508658-24-00 type B3 thymoma and thymic carcinoma 4
Early phase clinical trial to evaluate the safety of the combination of immunotherapy with dendritic cells pulsed and tumor lysate, together… Pending

2024-514052-32-00 Patients with newly diagnosed diffuse intrinsic pontine 1
Clinical trial evaluating the biological activity of a new drug identified as prifetrastat (PF-07248144), combined with fulvestrant for the … Pending

2025-521982-29-00 Adult patients with advanced hormone receptor positive 4
A Study to Determine the Effectiveness of a Test Drug ([68Ga]BED003) for the Detection of Pancreatic, Colorectal, Gastric, Breast and Ovaria… Pending

2025-521983-36-00 Colorectal cancer (CRC), gastric cancer (GC), pancreati 4